bosentan anhydrous has been researched along with Migraine Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baggio, DF; Chichorro, JG; Costa, NLVK; Lopes, RV; Rae, GA; Yuasa, GH | 1 |
| Hargreaves, RJ; Williamson, DJ | 1 |
1 review(s) available for bosentan anhydrous and Migraine Disorders
| Article | Year |
|---|---|
Neurogenic inflammation in the context of migraine.
Topics: Animals; Blood Proteins; Bosentan; Calcitonin Gene-Related Peptide; Capillary Permeability; Dihydroergotamine; Dura Mater; Humans; Migraine Disorders; Narcotics; Neurogenic Inflammation; Neurokinin-1 Receptor Antagonists; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Receptor, Serotonin, 5-HT1F; Receptors, Neurokinin-1; Receptors, Serotonin; Serotonin Receptor Agonists; Skull; Sulfonamides; Sumatriptan; Trigeminal Nerve; Vasoconstrictor Agents; Vasodilation | 2001 |
1 other study(ies) available for bosentan anhydrous and Migraine Disorders
| Article | Year |
|---|---|
Role of endothelin in the pathophysiology of migraine: A new view on an old player.
Topics: Animals; Bosentan; Calcitonin Gene-Related Peptide; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Female; Hyperalgesia; Migraine Disorders; Peptides, Cyclic; Rats; Rats, Wistar; Receptors, Endothelin | 2022 |